市场快照
| Study Period: | 2018 - 2026 |
| Base Year: | 2021 |
| Fastest Growing Market: | Asia Pacific |
| Largest Market: | North America |
| CAGR: | 6.8 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
市场概况
预计 G 蛋白偶联受体市场将受到癌症病例数量增加、生活方式相关问题（如心血管感染和呼吸系统问题）患病率上升的推动。G 蛋白偶联受体 (GPCR) 在新型药物的创新工作中非常有用。此外，政府对药物发现和开发方面的研发活动的资助预计将推动市场增长。此外，关于 GPCRs 药理成分的功能和结构文献证明了 GPCRs 靶点在治疗广泛的疾病方面的适应性效用，这有助于市场扩大。维护 GPCR 细胞系所涉及的高成本阻碍了 G 蛋白偶联受体 (GPCR) 市场的增长。
报告范围
G蛋白偶联受体（GPCR），也称为七跨膜受体或七螺旋受体，是一种位于细胞膜上的蛋白质，它与细胞外物质结合，并将这些物质的信号传递给称为G蛋白（鸟嘌呤核苷酸）的细胞内分子。结合蛋白）。GPCR 存在于多种生物体的细胞膜中，包括哺乳动物、植物、微生物和无脊椎动物。GPCR 的一些例子包括 β-肾上腺素受体，它结合肾上腺素，前列腺素 E2 受体，它结合称为前列腺素的炎症物质，以及视紫红质，它含有一种称为视网膜的光反应化学物质，它对眼睛中的视杆细胞接收到的光信号作出反应。
| By Assay Type | |
| Calcium Level Detection Assays | |
| Radioligand Binding and GTPγS Functional Assays | |
| cAMP Assays and cGMP Assays | |
| β-Arrestin Functional Assays | |
| Reporter Gene Assays | |
| Other Assay Types |
| By Application | |
| Cardiovascular System | |
| Central Nervous System (CNS) | |
| Oncology | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
主要市场趋势
按治疗领域估计，肿瘤学将主导全球 G 蛋白偶联受体 (GPCR) 市场
超过 700 个基因被鉴定为 G 蛋白偶联受体，它们构成了人类基因组中最大的蛋白质超家族。GPCR 在干扰从感觉调节到激素反应的各种生理事件方面发挥着至关重要的作用。最近，基础和临床研究人员的重点关注表明，通过 GPCR 发出的信号会影响癌症生物学的各个方面，例如侵袭、迁移和血管重塑。因此，GPCR靶向药物的开发将为治疗各种类型的癌症提供一种新的治疗策略。由于 GPCR 信号是肿瘤生长和转移的重要因素，因此辨别 G蛋白如何-偶联受体激酶 (GRK) 调节癌细胞中的 GPCR 活性可能会极大地提高对肿瘤发生和肿瘤发生的理解，并有助于开发新的抗癌疗法。
To understand key trends, Download Sample Report
亚太地区有望实现快速复合年增长率
由于中国和印度等国家的经济发展，以及政府对生物技术和生物制药领域的投资增加，预期寿命延长，亚太地区预计在预测期内将以显着速度增长，人均收入增加，以及该地区未满足的市场需求。此外，由于 Sosei Heptares 和 NB Health Laboratory 等几家新兴公司的存在，预计亚太地区将成为增长最快的区域市场。公司为提高市场占有率而采取的增长举措数量推动了区域增长。
To understand geography trends, Download Sample Report
竞争格局
全球 G 蛋白偶联受体 (GPCR) 市场的参与者通过采用无机增长战略（如收购、合并和合作伙伴关系），专注于扩大其产品组合。例如，2018 年 6 月，安进的 erenumab 获得 FDA 批准，成为第一个 G 蛋白偶联受体靶向抗体。尽管面临各种挑战，但仍有几种生物制剂处于制造过程中。
 market Image 3.png)
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Growing Demand for GPCR assays in Drug Discovery Studies
-
4.2.2 Wide Range Applications of GPCRs in the Treatment for Various Medical Conditions
-
4.2.3 Increasing prevalence of chronic Diseases
-
-
4.3 Market Restraints
-
4.3.1 Challenges with the purification of GPCRs
-
4.3.2 Complexity of the GPCR Signalling System
-
-
4.4 Porter's Five Forces Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Assay Type
-
5.1.1 Calcium Level Detection Assays
-
5.1.2 Radioligand Binding and GTPγS Functional Assays
-
5.1.3 cAMP Assays and cGMP Assays
-
5.1.4 β-Arrestin Functional Assays
-
5.1.5 Reporter Gene Assays
-
5.1.6 Other Assay Types
-
-
5.2 By Application
-
5.2.1 Cardiovascular System
-
5.2.2 Central Nervous System (CNS)
-
5.2.3 Oncology
-
5.2.4 Others
-
-
5.3 Geography
-
5.3.1 North America
-
5.3.1.1 United States
-
5.3.1.2 Canada
-
5.3.1.3 Mexico
-
-
5.3.2 Europe
-
5.3.2.1 Germany
-
5.3.2.2 United Kingdom
-
5.3.2.3 France
-
5.3.2.4 Italy
-
5.3.2.5 Spain
-
5.3.2.6 Rest of Europe
-
-
5.3.3 Asia-Pacific
-
5.3.3.1 China
-
5.3.3.2 Japan
-
5.3.3.3 India
-
5.3.3.4 Australia
-
5.3.3.5 South Korea
-
5.3.3.6 Rest of Asia-Pacific
-
-
5.3.4 Middle East & Africa
-
5.3.4.1 GCC
-
5.3.4.2 South Africa
-
5.3.4.3 Rest of Middle East & Africa
-
-
5.3.5 South America
-
5.3.5.1 Brazil
-
5.3.5.2 Argentina
-
5.3.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Abcam PLC
-
6.1.2 Becton, Dickinson and Company
-
6.1.3 PerkinElmer Inc.
-
6.1.4 Merck KGaA
-
6.1.5 Enzo Biochem Inc. (Enzo Life Sciences Inc.)
-
6.1.6 Danaher Corporation (Molecular Devices LLC)
-
6.1.7 Promega Corporation
-
6.1.8 Bioinvenu Corporation
-
6.1.9 Thermo Fisher Scientific Inc.
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The G-Protein Coupled Receptors (GPCR) Market market is studied from 2018 - 2026.
What is the growth rate of G-Protein Coupled Receptors (GPCR) Market?
The G-Protein Coupled Receptors (GPCR) Market is growing at a CAGR of 6.8% over the next 5 years.
Which region has highest growth rate in G-Protein Coupled Receptors (GPCR) Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in G-Protein Coupled Receptors (GPCR) Market?
North America holds highest share in 2021.
Who are the key players in G-Protein Coupled Receptors (GPCR) Market?
Abcam PLC, Enzo Life Sciences Inc., Promega Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc. are the major companies operating in G-Protein Coupled Receptors (GPCR) Market.
